Ning Wu

3.0k total citations · 1 hit paper
74 papers, 2.3k citations indexed

About

Ning Wu is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ning Wu has authored 74 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 18 papers in Physiology and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ning Wu's work include Pain Mechanisms and Treatments (12 papers), Receptor Mechanisms and Signaling (8 papers) and Botulinum Toxin and Related Neurological Disorders (7 papers). Ning Wu is often cited by papers focused on Pain Mechanisms and Treatments (12 papers), Receptor Mechanisms and Signaling (8 papers) and Botulinum Toxin and Related Neurological Disorders (7 papers). Ning Wu collaborates with scholars based in China, United States and Czechia. Ning Wu's co-authors include Lewis C. Cantley, Jin Li, Jennifer Wen, Bin Zheng, Timothy E. McGraw, John M. Asara, Gary Bellinger, Adam J. Shaywitz, Che-Hung Shen and Barbara B. Kahn and has published in prestigious journals such as Molecular Cell, PLoS ONE and Scientific Reports.

In The Last Decade

Ning Wu

73 papers receiving 2.3k citations

Hit Papers

AMPK-Dependent Degradation of TXNIP upon Energy Stress Le... 2013 2026 2017 2021 2013 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ning Wu China 20 1.2k 438 323 192 184 74 2.3k
Jennifer B. Collins United States 28 1.4k 1.1× 265 0.6× 239 0.7× 179 0.9× 145 0.8× 39 2.7k
Jing Zheng United States 39 1.6k 1.3× 552 1.3× 489 1.5× 209 1.1× 220 1.2× 152 4.3k
Fei Cai China 25 675 0.5× 239 0.5× 131 0.4× 219 1.1× 106 0.6× 86 2.0k
Ellen Fritsche Germany 38 1.5k 1.2× 356 0.8× 476 1.5× 424 2.2× 113 0.6× 126 4.2k
Jun Yin China 25 1.3k 1.1× 446 1.0× 269 0.8× 294 1.5× 81 0.4× 118 2.6k
Jason Matthews Canada 36 2.1k 1.7× 321 0.7× 823 2.5× 153 0.8× 178 1.0× 100 5.9k
Valentina Pallottini Italy 32 1.0k 0.8× 325 0.7× 245 0.8× 262 1.4× 593 3.2× 83 2.7k
Masahisa Horiuchi Japan 24 931 0.8× 610 1.4× 79 0.2× 183 1.0× 216 1.2× 91 2.1k
Keiko Nohara Japan 27 1.4k 1.1× 256 0.6× 520 1.6× 74 0.4× 77 0.4× 90 4.3k

Countries citing papers authored by Ning Wu

Since Specialization
Citations

This map shows the geographic impact of Ning Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Wu more than expected).

Fields of papers citing papers by Ning Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ning Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Wu. The network helps show where Ning Wu may publish in the future.

Co-authorship network of co-authors of Ning Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Ning Wu. A scholar is included among the top collaborators of Ning Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ning Wu. Ning Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, L. H., Yongheng Wang, Shoufang Jiang, et al.. (2025). Caspase-1 inhibitor VX-765 alleviates PM2.5-induced hepatic lipid metabolism disorder in mice. ScienceAsia. 51(2). 1–1. 1 indexed citations
2.
Ge, Weigong, Beverly Lyn‐Cook, Huixiao Hong, et al.. (2025). AI-powered topic modeling: comparing LDA and BERTopic in analyzing opioid-related cardiovascular risks in women. Experimental Biology and Medicine. 250. 10389–10389. 6 indexed citations
3.
Li, Lixia, Ying Shi, Zhengde Lu, et al.. (2024). High-mobility group box 1 and its related receptors: potential therapeutic targets for contrast-induced acute kidney injury. International Urology and Nephrology. 56(7). 2291–2299. 5 indexed citations
4.
Liu, Mengnan, et al.. (2023). Insights into the Involvement and Therapeutic Target Potential of the Dopamine System in the Posttraumatic Stress Disorder. Molecular Neurobiology. 60(7). 3708–3723. 4 indexed citations
5.
Yang, Zicong, Lei Shi, Ying Shi, et al.. (2022). Vaspin Alleviates Sepsis-Induced Cardiac Injury and Cardiac Inflammation by Inhibiting Kallikrein 7 in Mice. Mediators of Inflammation. 2022. 1–12. 5 indexed citations
6.
Dağdeviren, Sezin, Richard Lee, & Ning Wu. (2022). Physiological and Pathophysiological Roles of Thioredoxin Interacting Protein: A Perspective on Redox Inflammation and Metabolism. Antioxidants and Redox Signaling. 38(4-6). 442–460. 12 indexed citations
7.
Yao, Ye, Lijing L. Yan, Han Chen, et al.. (2020). Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids. Phytomedicine. 77. 153268–153268. 184 indexed citations
8.
Zhu, Lihui, et al.. (2019). Integrating miRNA and mRNA expression profiles in plasma of laying hens associated with heat stress. Molecular Biology Reports. 46(3). 2779–2789. 16 indexed citations
10.
Wang, Wenbo, Linlin Zhao, Zhen‐Yu He, et al.. (2018). Metabolomics-based evidence of the hypoglycemic effect of Ge-Gen-Jiao-Tai-Wan in type 2 diabetic rats via UHPLC-QTOF/MS analysis. Journal of Ethnopharmacology. 219. 299–318. 53 indexed citations
11.
Wang, Wenbo, Ling Jin, Ning Wu, et al.. (2017). iTRAQ‐Based Quantitative Proteomics Analysis of the Protective Effect of Yinchenwuling Powder on Hyperlipidemic Rats. Evidence-based Complementary and Alternative Medicine. 2017(1). 7 indexed citations
12.
Wu, Ning, et al.. (2017). (378) Trigeminal neuralgia: pharmacotherapy and surgical treatment patterns in the United States. Journal of Pain. 18(4). S69–S69. 2 indexed citations
13.
Wu, Ning, Yuling Zhang, Hai-Tian Wang, et al.. (2016). Overexpression of hepatocyte nuclear factor 4α in human mesenchymal stem cells suppresses hepatocellular carcinoma development through Wnt/β-catenin signaling pathway downregulation. Cancer Biology & Therapy. 17(5). 558–565. 41 indexed citations
14.
Peng, Xiaomei, et al.. (2013). Utilization of duloxetine and celecoxib in osteoarthritis patients. Current Medical Research and Opinion. 29(9). 1161–1169. 4 indexed citations
15.
Yan, Hai‐Tao, Ning Wu, Xin‐Qiang Lu, et al.. (2012). Aquaporin‐4 Deficiency Attenuates Opioid Dependence through Suppressing Glutamate Transporter‐1 Down‐regulation and Maintaining Glutamate Homeostasis. CNS Neuroscience & Therapeutics. 19(1). 12–19. 17 indexed citations
16.
Wu, Ning, et al.. (2011). Opioid Receptor Trafficking and Signaling: What Happens After Opioid Receptor Activation?. Cellular and Molecular Neurobiology. 32(2). 167–184. 17 indexed citations
17.
Wu, Ning, et al.. (2010). Opioid use and healthcare costs among patients with DPNP initiating duloxetine versus other treatments. Current Medical Research and Opinion. 26(10). 2507–2516. 9 indexed citations
18.
Li, Fei, Ning Wu, Ruibin Su, et al.. (2009). Comparison of agmatine with moxonidine and rilmenidine in morphine dependence in vitro: Role of imidazoline I1 receptors. European Journal of Pharmacology. 612(1-3). 1–8. 12 indexed citations
19.
Wang, Jifang, Zhiyuan Wang, Ning Wu, Hai‐Tao Yan, & Jin Li. (2009). Effects of aquaporin4 deficiency on opioid receptors characteristics in naive and chronic morphine-treated mice. Neuroscience Letters. 457(3). 111–114. 9 indexed citations
20.
Meng, Ge, Ning Wu, Cheng Zhang, et al.. (2008). Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence. European Journal of Pharmacology. 586(1-3). 130–138. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026